James Cho - 01 Feb 2024 Form 4 Insider Report for Gritstone bio, Inc.

Role
SVP, CHIEF ACCOUNTING OFFICER
Signature
/s/ James Cho
Issuer symbol
N/A
Transactions as of
01 Feb 2024
Net transactions value
$0
Form type
4
Filing time
05 Feb 2024, 19:03:48 UTC
Previous filing
06 Feb 2023
Next filing
17 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTS Common Stock Award $0 +18,000 +15% $0.000000 138,644 01 Feb 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTS Stock Option (Right to Buy) Award $0 +109,000 $0.000000 109,000 01 Feb 2024 Common Stock 109,000 $2.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") of which 1/2 vests on the first anniversary of the grant date, with the remainder of grant vesting on the second anniversary of the grant date, subject to the continued service of the Reporting Person on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Includes 14,916 shares of Common Stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c) and 76,836 RSUs which are subject to vesting.
F3 The option vests as to 1/24th of the total grant monthly beginning February 1, 2024 until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date.